A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Disease
Trial Locations (7)

Unknown

Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno (CEMIC), CABA

Hospital Britanico de Buenos Aires, CABA

Hospital de Gastroenterologia Dr. Carlos Bonorino Udaondo, CABA

Sanatorio Mater Dei, CABA

Hospital San Martin, La Plata

Hospital Provincial del Centenario, Rosario

Hospital Privado de Cordoba, Córdoba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03488030 - A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) | Biotech Hunter | Biotech Hunter